2 - Second Qatar Allergy Conference
  • ISSN: 0253-8253
  • EISSN: 2227-0426


Common variable immunodeficiency (CVID) is a complex inborn error of humoral immunity with complications of both infectious and non-infectious origins. Classifications of CVID patients provide a clearer understanding of the pathogenesis, prediction, and management of non-infectious complications. This study aims to classify Moroccan CVID patients based on the European classification (EUROclass).

We recruited 20 CVID patients meeting standard diagnostic criteria (5-6). After collecting clinical and demographic data, we used flow cytometry to analyze B-cell subsets and group patients and assess the relation of each group with clinical manifestations.

90% of the patients in our cohort study had a history of respiratory infections. The non-infectious manifestations included splenomegaly, autoimmunity, lymphadenopathy, and granulomatous diseases diagnosed in 50%, 45%, 40%, and 25% of patients, respectively. We observed significant co-occurrence of splenomegaly with autoimmunity and granulomatous diseases to a lesser extent. Patients had a significant reduction in total, switched memory, marginal zone-like, plasma blasts, and a substantial increase in the percentage of activated B cells, suggesting a defect in the late phases of B-cell differentiation. This condition was linked with an increased occurrence of splenomegaly and granulomatous affections. Besides, patients also had an expansion of CD21low B-cells, which was strongly associated with splenomegaly.

The classification of the first Moroccan cohort of CVID patients showed agreement with previous results. It suggests the possibility of adopting this approach on a global scale for better diagnosis and follow-up of CVID patients.


Article metrics loading...

Loading full text...

Full text loading...


  1. Hammarstrom, L., I. Vorechovsky, and D. Webster, Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol, 2000. 120:(2): p. 225-31.
    [Google Scholar]
  2. Modell, V., et al., Global overview of primary immunodeficiencies: a worldwide report from Jeffrey Modell Centers focused on diagnosis, treatment, and discovery. Immunol Res, 2014. 60:(1):p. 132-44.
    [Google Scholar]
  3. Wehr, C., et al., The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood, 2008. 111:(1): p. 77-85.
    [Google Scholar]
  4. Bousfiha, A., et al., The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity. J Clin Immunol, 2022.
    [Google Scholar]
  5. Aghamohammadi, A., et al., Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency. Clin Diagn Lab Immunol, 2005. 12:(7): p. 825-32.
    [Google Scholar]
  6. Warnatz, K., et al., Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood, 2002. 99:(5): p. 1544-51.
    [Google Scholar]
  7. Yazdani, R., et al., Comparison of various classifications for patients with common variable immunodeficiency (CVID) using measurement of B-cell subsets. Allergol Immunopathol (Madr), 2017. 45:(2): p. 183-192.
    [Google Scholar]
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error